The adoption of telemedicine and remote monitoring technologies in ophthalmology to accelerate the <a target=_blank href= ...

BEDFORD, Mass., Feb. 03, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: OCUL, “Ocular”), a biopharmaceutical company committed to ...

OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain (NCP), a severe ocular condition without an ...

Sen. Angela Alsobrooks (D-Md.) on Thursday grilled Department of Health and Human Services secretary nominee Robert F. Kennedy Jr. on his history of claiming Black Americans have a better immune ...

Aggressive treatment before ocular surgery helps avoid postoperative issues with visual quality in patients with dry eye ...

LONDON - OKYO Pharma Limited (NASDAQ: OKYO), a biopharmaceutical company engaged in developing treatments for ocular ...

Retinopathy of Prematurity (ROP) currently stands as a major contributor to childhood blindness across the globe, particularly prevalent in middle and ...

As a retina specialist, one of the most important aspects of eye care I focus on is the prevention and treatment of diabetic retinopathy. This condition is a leading cause of blindness in adults, yet ...

( MENAFN - Mid-East Info) DUBAI, United Arab Emirates; January 2025 - Mayo clinic researchers have developed organoid models to study uveal melanoma, one of the most common types of eye cancer in ...

Mayo Clinic researchers have developed organoid models to study uveal melanoma, one of the most common types of eye cancer in ...

ROCHESTER, Minnesota — Mayo Clinic researchers have developed  organoid models  to study  uveal melanoma , one of the most common types of eye cancer ...

Glaucoma Treatment MarketThe global glaucoma treatment market, valued at USD 5.7 billion in 2022, is projected to grow at a ...